Adaptive Biotechnologies GAAP EPS of -0.33 beats by 0.02, revenue of 41.87M beats by 3.09M
| ADPT Stock | USD 3.21 0.10 3.02% |
Slightly above 63% of Adaptive Biotechnologies' investor base is looking to short. The analysis of overall sentiment of trading Adaptive Biotechnologies Corp stock suggests that many investors are alarmed at this time. Adaptive Biotechnologies' investor sentiment overview provides quick insight into current market opportunities from investing in Adaptive Biotechnologies Corp. The current market sentiment, together with Adaptive Biotechnologies' historical and current headlines, can help investors time the market. In addition, many technical investors use Adaptive Biotechnologies stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Adaptive |
Adaptive Biotechnologies reports Q1 earnings, beating expectations with a GAAP EPS of -0.33 and revenue of 41.87M, showcasing a 11.4 percent YoY increase.
Read at seekingalpha.com
 |
Adaptive Biotechnologies Current Investor Sentiment
Panic Vs Confidence
37
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Adaptive Biotechnologies' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Adaptive Biotechnologies Corp.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentDisposing |
Adaptive Biotechnologies Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Adaptive Biotechnologies can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Adaptive Biotechnologies Historical Investor Sentiment
Investor biases related to Adaptive Biotechnologies' public news can be used to forecast risks associated with an investment in Adaptive. The trend in average sentiment can be used to explain how an investor holding Adaptive can time the market purely based on public headlines and social activities around Adaptive Biotechnologies Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Adaptive Biotechnologies' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Adaptive Biotechnologies and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Adaptive Biotechnologies news discussions. The higher the estimate score, the more favorable the investor's outlook on Adaptive Biotechnologies.
Adaptive Biotechnologies Fundamental Analysis
We analyze Adaptive Biotechnologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adaptive Biotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adaptive Biotechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Asset
Current Asset Comparative Analysis
Adaptive Biotechnologies is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Adaptive Biotechnologies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Adaptive Biotechnologies stock to make a market-neutral strategy. Peer analysis of Adaptive Biotechnologies could also be used in its relative valuation, which is a method of valuing Adaptive Biotechnologies by comparing valuation metrics with similar companies.
Peers
Adaptive Biotechnologies Related Equities
| DOMH | Dominari Holdings | 4.52 | ||||
| KO | Coca Cola | 1.55 | ||||
| CSCO | Cisco Systems | 0.32 | ||||
| VALN | Valneva SE | 0.11 | ||||
| PG | Procter Gamble | 0.07 | ||||
| MMM | 3M | 0.38 | ||||
| JPM | JPMorgan Chase | 0.40 | ||||
| INTC | Intel | 1.82 | ||||
| GE | GE Aerospace | 2.23 | ||||
| HPQ | HP | 3.23 |
Additional Tools for Adaptive Stock Analysis
When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.